Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond

M Li, MH Younis, Y Zhang, W Cai, X Lan - European journal of nuclear …, 2022 - Springer
Fibroblast activation protein (FAP) is a type II membrane-bound glycoprotein which is
overexpressed in cancer-associated fibroblasts and activated fibroblasts at wound …

The lymphatic system and sentinel lymph nodes: conduit for cancer metastasis

SP Leong, A Pissas, M Scarato, F Gallon… - Clinical & experimental …, 2022 - Springer
The lymphatic system is a complicated system consisting of the lymphatic vessels and lymph
nodes draining the extracellular fluid containing cellular debris, excess water and toxins to …

Pancreatic cystic lesions and malignancy: assessment, guidelines, and the field defect

FH Miller, C Lopes Vendrami, HS Recht, CG Wood… - Radiographics, 2022 - pubs.rsna.org
The widespread use of high–spatial-resolution cross-sectional imaging has led to an
increase in detection of incidental pancreatic cystic lesions. These lesions are a diverse …

Management of gastrointestinal neuroendocrine tumors

R Wang, R Zheng-Pywell, HA Chen… - Clinical Medicine …, 2019 - journals.sagepub.com
Neuroendocrine neoplasms (NENs) are derived from neuroendocrine cell system and can
have benign or malignant characteristics. They are rare tumors, but have been increasing in …

Clinical Utility of 18F-FDG PET in Neuroendocrine Tumors Prior to Peptide Receptor Radionuclide Therapy: A Systematic Review and Meta-Analysis

E Alevroudis, ME Spei, SN Chatziioannou, M Tsoli… - Cancers, 2021 - mdpi.com
Simple Summary Functional imaging with 18F-fluorodeoxyglucose positron emission
tomography (18F-FDG PET) has evolved into a major clinical tool in cancer diagnosis and …

Recent Advances in 64Cu/67Cu-Based Radiopharmaceuticals

OO Krasnovskaya, D Abramchuck, A Erofeev… - International Journal of …, 2023 - mdpi.com
Copper-64 (T1/2= 12.7 h) is a positron and beta-emitting isotope, with decay characteristics
suitable for both positron emission tomography (PET) imaging and radiotherapy of cancer …

PET/CT imaging in treatment planning and surveillance of sinonasal neoplasms

S Akay, JH Pollard, A Saad Eddin, A Alatoum… - Cancers, 2023 - mdpi.com
Simple Summary Sinonasal cancers are rare types of cancer that are often detected at a late
stage, making them difficult to treat. To monitor these cancers closely, advanced imaging …

[HTML][HTML] Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors

J Ramage, BG Naraev, TR Halfdanarson - Seminars in oncology, 2018 - Elsevier
ABSTRACT 177 Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) is now
approved for patients with advanced gastroenteropancreatic neuroendocrine tumors (NET) …

Neuroendocrine neoplasms of the gynecologic tract

M Virarkar, SS Vulasala, AC Morani, R Waters… - Cancers, 2022 - mdpi.com
Simple Summary Neuroendocrine refers to the cells that synthesize and secrete messenger
chemicals such as neuropeptides and amines. Neuroendocrine neoplasms (NENs) are …

Advances in macrocyclic chelators for positron emission tomography imaging

M Li, S Wang, Q Kong, X Cheng, H Yan, Y Xing, X Lan… - View, 2023 - Wiley Online Library
In recent years, radiometals have been successfully applied to medicine because of their
breadth of decay properties and increased production and availability. Bifunctional chelators …